NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-211 Cr | ₹-247 Cr | ₹-363 Cr | ₹35 Cr | ₹-186 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-211 Cr |
| Mar2024 | ₹-247 Cr |
| Mar2023 | ₹-363 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹-186 Cr |
How is Cash Flow from Financing Activities of NATCO PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-211 Cr | Negative | |
| Mar2024 | ₹-247 Cr | Negative | |
| Mar2023 | ₹-363 Cr | Negative | |
| Mar2022 | ₹35 Cr | Positive | |
| Mar2021 | ₹-186 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹17,949.4 Cr | 3.1% | 21.1% | 29.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 3.1% |
21.1% |
29.7% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses